About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Pennsylvania | 623 Studies

Clinical Trials Prostate CancerPennsylvania

Prostate Cancer Clinical Trials in Pennsylvania

Find 623 clinical trials for prostate cancer near Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 623 trials

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others CompletedPhase 3 Study of Immunotherapy to Treat Advanced Prostate CancerThe purpose of this study is to determine if asymptomatic or minimally symptomatic patients with metastatic prostate cancer who have not received chemotherapy live longer when…NCT01057810·Anchorage, Alaska and 133 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasThe purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of…NCT04104776·Tampa, Florida and 79 others

CompletedDendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerThis study will evaluate the feasibility, safety, and efficacy of intradermal vaccination of prostate cancer patients with alpha-type-1-polarized dendritic cells (DC1) loaded with…NCT00970203·Pittsburgh, Pennsylvania

TerminatedStudy to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsThe purpose of this study is to test the combination of an experimental drug known as MGCD0103 given along with an FDA-approved drug called docetaxel.NCT00511576·Baltimore, Maryland and 1 other

TerminatedPain Control in Patients With Recurrent or Metastatic Breast or Prostate CancerRATIONALE: An outpatient educational and behavioral skills training program may help patients with metastatic breast or prostate cancer live longer and more comfortably.NCT00002668·Urbana, Illinois and 17 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

CompletedTreatment Preference and Patient Centered Prostate Cancer CareThe purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of…NCT02032550·Philadelphia, Pennsylvania and 2 others

TerminatedPhase II, Dose Finding Study of GTx-758The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.NCT01393119·Glendale, Arizona and 20 others

CompletedA Registry for Hereditary Cancer Risk Assessment and Genetic TestingThis prospective registry will evaluate the feasibility and impact of implementing standard cancer family history review and guideline-aligned genetic testing for men diagnosed…NCT04015102·Little Rock, Arkansas and 9 others

CompletedSafety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerThe purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.NCT02003924·Tucson, Arizona and 396 others

CompletedSildenafil in Treating Erectile Dysfunction in Patients With Prostate CancerRATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual…NCT00057759·Concord, California and 29 others

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

Active not recruitingA Study of ARV-766 Given by Mouth in Men With Metastatic Prostate CancerThis first-in-human, Phase 1/2, open-label study evaluates the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of JSB462 (luxdegalutamide, previously…NCT05067140·Duarte, California and 16 others

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

CompletedCASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneThis is a phase II clinical trial in patients with metastatic castration sensitive prostate cancer.NCT03934840·Phoenix, Arizona and 7 others

RecruitingAnti-inflammatory Drugs and Serum Prostate-Specific Antigen TestProstate cancer is the most frequently diagnosed cancer in men in the Unites States.NCT05629494·Chicago, Illinois and 2 others

CompletedAASUR in High Risk Prostate CancerThe purpose of this study is to determine whether anti-testosterone medications, when administered before, during, and after high-dose, precision radiation, will be effective in…NCT02772588·Baltimore, Maryland and 10 others

CompletedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesEnthuse M1 is a large phase III clinical trial studying the safety and efficacy of ZD4054 (Zibotentan) in patients with hormone resistant prostate cancer and bone metastases.NCT00554229·Tucson, Arizona and 196 others

CompletedSafety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorThis study is designed to assess the safety and tolerability of atezolizumab when given in combination with radium-223 dichloride in participants with metastatic CRPC who have…NCT02814669·Duarte, California and 16 others

PreviousPage 10 of 32Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma